What determines the success or failure of intracellular cutaneous parasites? Lessons learned from leishmaniasis

Medical Microbiology and Immunology

Volumn 198, Issue 3, 2009, Pages 137-146

  Maurer, Marcus ^a   Dondji, Blaise ^b   Von Stebut, Esther ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CENTRAL WASHINGTON UNIVERSITY   (United States)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Adaptive immunity; Innate immunity; Leishmania; Skin immune system

Indexed keywords

CYTOKINE; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INNATE IMMUNITY; LEISHMANIA; NONHUMAN; PARASITE TRANSMISSION; PRIORITY JOURNAL; REVIEW; SKIN FUNCTION; SKIN LEISHMANIASIS; TH1 CELL; TH2 CELL;

ANIMALS; CYTOKINES; DENDRITIC CELLS; IMMUNITY, INNATE; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MAST CELLS; SKIN;

EID: 68349095161     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-009-0114-9     Document Type: Review

References (77)

1. BL Herwaldt 1999 Leishmaniasis Lancet 354 1191 10.1016/S0140-6736(98) 10178-2 (Pubitemid 29460458)
2. P Launois F Tacchini-Cottier C Parra-Lopez JA Louis 1998 Cytokines in parasitic diseases: the example of cutaneous leishmaniasis Int Rev Immunol 17 157
3. W Solbach T Laskay 2000 The host response to Leishmania infection Adv Immunol 74 275 10.1016/S0065-2776(08)60912-8
4. R Etges I Muller 1998 Progressive disease or protective immunity to Leishmania major infection: the result of a network of stimulatory and inhibitory interactions J Mol Med 76 372 10.1007/s001090050230 (Pubitemid 28218640)
5. B Dondji DD Duhlinska A Same-Ekobo I Yimagou 1998 Clinical and parasitological prevalence of cutaneous leishmaniasis in Mokolo focus, Far North Province of Cameroon Bull Liais Doc OCEAC 31 40
6. P Couppie E Clyti D Sainte-Marie JP Dedet B Carme R Pradinaud 2004 Disseminated cutaneous leishmaniasis due to Leishmania guyanensis: case of a patient with 425 lesions Am J Trop Med Hyg 71 558
7. D Sacks N Noben-Trauth 2002 The immunology of susceptibility and resistance to Leishmania major in mice Nat Rev Immunol 2 845 10.1038/nri933 (Pubitemid 37328707)
8. S Romagnani 1991 Human TH1 and TH2 subsets: doubt no more Immunol Today 12 256 10.1016/0167-5699(91)90120-I
9. KA Rogers GK DeKrey ML Mbow RD Gillespie CI Brodskyn RG Titus 2002 Type 1 and type 2 responses to Leishmania major FEMS Microbiol Lett 209 1 10.1111/j.1574-6968.2002.tb11101.x
10. SG Reed P Scott 1993 T-cell and cytokine responses in leishmaniasis Curr Opin Immunol 5 524 10.1016/0952-7915(93)90033-O (Pubitemid 23250290)
11. MM Kane DM Mosser 2001 The role of IL-10 in promoting disease progression in leishmaniasis J Immunol 166 1141
12. R Medzhitov 2001 Toll-like receptors and innate immunity Nat Rev Immunol 1 135 10.1038/35100529
13. Y Lai RL Gallo 2008 Toll-like receptors in skin infections and inflammatory diseases Infect Disord Drug Targets 8 144
14. JL Curry JZ Qin B Bonish R Carrick P Bacon J Panella J Robinson BJ Nickoloff 2003 Innate immune-related receptors in normal and psoriatic skin Arch Pathol Lab Med 127 178
15. PI Song YM Park T Abraham B Harten A Zivony N Neparidze CA Armstrong JC Ansel 2002 Human keratinocytes express functional CD14 and toll-like receptor 4 J Invest Dermatol 119 424 10.1046/j.1523-1747.2002.01847.x (Pubitemid 35001953)
16. S Thoma-Uszynski S Stenger O Takeuchi MT Ochoa M Engele PA Sieling PF Barnes M Rollinghoff PL Bolcskei M Wagner S Akira MV Norgard JT Belisle PJ Godowski BR Bloom RL Modlin 2001 Induction of direct antimicrobial activity through mammalian toll-like receptors Science 291 1544 10.1126/science.291.5508. 1544 (Pubitemid 32179220)
17. E Muraille C De Trez M Brait P De Baetselier O Leo Y Carlier 2003 Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response J Immunol 170 4237
18. S Lopez Kostka J Knop A Konur MC Udey E von Stebut 2006 Distinct roles for IL-1 receptor type I signaling in early versus established Leishmania major infections J Invest Dermatol 126 1582 10.1038/sj.jid.5700309 (Pubitemid 43910375)
19. MK Liszewski TC Farries DM Lublin IA Rooney JP Atkinson 1996 Control of the complement system Adv Immunol 61 201 10.1016/S0065-2776(08)60868-8
20. SS Asghar MC Pasch 1998 Complement as a promiscuous signal transduction device Lab Invest 78 1203
21. ES Reis JA Barbuto L Isaac 2006 Human monocyte-derived dendritic cells are a source of several complement proteins Inflamm Res 55 179 10.1007/s00011-006-0068-y (Pubitemid 44035068)
22. MC Pasch NH Van Den Bosch MR Daha JD Bos SS Asghar 2000 Synthesis of complement components C3 and factor B in human keratinocytes is differentially regulated by cytokines J Invest Dermatol 114 78 10.1046/j.1523-1747.2000.00841.x (Pubitemid 30195976)
23. Y Katz O Nadiv MJ Rapoport M Loos 2000 IL-17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts Clin Exp Immunol 120 22 10.1046/j.1365-2249.2000.01199.x
24. A Fayyazi R Sandau LQ Duong O Götze HJ Radzun S Schweyer A Soruri J Zwirner 1999 C5a receptor and interleukin-6 are expressed in tissue macrophages and stimulated keratinocytes but not in pulmonary and intestinal epithelial cells Am J Pathol 154 495
25. W Füreder H Agis M Willheim HC Bankl U Maier K Kishi MR Müller K Czerwenka T Radaszkiewicz JH Butterfield GW Klappacher WR Sperr M Oppermann K Lechner P Valent 1995 Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells J Immunol 155 3152
26. J Wojta C Kaun G Zorn M Ghannadan AW Hauswirth WR Sperr G Fritsch D Printz BR Binder G Schatzl J Zwirner G Maurer K Huber P Valent 2002 C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils Blood 100 517 10.1182/blood.V100.2.517 (Pubitemid 34761114)
27. T Werfel K Kirchhoff M Wittmann G Begemann A Kapp F Heidenreich O Götze J Zwirner 2000 Activated human T lymphocytes express a functional C3a receptor J Immunol 165 6599
28. M Dominguez I Moreno C Aizpurua A Torano 2003 Early mechanisms of Leishmania infection in human blood Microbes Infect 5 507 10.1016/S1286-4579(03) 00071-6 (Pubitemid 36570478)
29. AA Itano MK Jenkins 2003 Antigen presentation to naive CD4 T cells in the lymph node Nat Immunol 4 733 10.1038/ni957 (Pubitemid 36986756)
30. RN Germain MK Jenkins 2004 In vivo antigen presentation Curr Opin Immunol 16 120 10.1016/j.coi.2003.11.001 (Pubitemid 38198126)
31. C Reis e Sousa SD Diebold AD Edwards N Rogers O Schulz R Spörri 2003 Regulation of dendritic cell function by microbial stimuli Pathol Biol (Paris) 51 67 10.1016/S0369-8114(03)00099-3 (Pubitemid 36427573)
32. U Ritter A Meissner C Scheidig H Körner 2004 CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis Eur J Immunol 34 1542 10.1002/eji.200324586 (Pubitemid 39256035)
33. L Wu A Dakic 2004 Development of dendritic cell system Cell Mol Immunol 1 112
34. B León M López-Bravo C Ardavín 2007 Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania Immunity 26 519 10.1016/j.immuni.2007.01.017 (Pubitemid 46602998)
35. T Baldwin S Henri J Curtis M O'Keeffe D Vremec K Shortman E Handman 2004 Dendritic cell populations in Leishmania major-infected skin and draining lymph nodes Infect Immun 72 1991 10.1128/IAI.72.4.1991-2001.2004 (Pubitemid 38419910)
36. Y Belkaid S Mendez R Lira N Kadambi G Milon D Sacks 2000 A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity J Immunol 165 969
37. E von Stebut M Metz G Milon J Knop M Maurer 2003 Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1α/β released from neutrophils recruited by mast cell-derived TNFα Blood 101 210 10.1182/blood-2002-03-0921 (Pubitemid 36025910)
38. M Maurer S Lopez Kostka F Siebenhaar K Moelle M Metz J Knop E von Stebut 2006 Skin mast cells control T cell-dependent host defense in Leishmania major infections FASEB J 20 2460 10.1096/fj.06-5860com (Pubitemid 44953818)
39. M Maurer E von Stebut 2004 Macrophage inflammatory protein-1 Int J Biochem Cell Biol 36 1882 1886 10.1016/j.biocel.2003.10.019 (Pubitemid 38760018)
40. E von Stebut 2007 Cutaneous Leishmania infection: progress in pathogenesis research and experimental therapy Exp Dermatol 16 340 10.1111/j.1600-0625.2007.00554.x (Pubitemid 46394850)
41. E von Stebut 2007 Immunology of cutaneous leishmaniasis: the role of mast cells, phagocytes and dendritic cells for protective immunity Eur J Dermatol 17 115
42. TM Hornell GW Beresford A Bushey JM Boss ED Mellins 2003 Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor J Immunol 171 2374
43. F Woelbing SL Kostka K Moelle Y Belkaid C Sunderkoetter S Verbeek A Waisman AP Nigg J Knop MC Udey E von Stebut 2006 Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity J Exp Med 203 177 10.1084/jem.20052288 (Pubitemid 43139656)
44. JJ Campbell G Haraldsen J Pan J Rottman S Qin P Ponath DP Andrew R Warnke N Ruffing N Kassam L Wu EC Butcher 1999 The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells Nature 400 776 10.1038/23495 (Pubitemid 29399540)
45. JJ Campbell EC Butcher 2000 Chemokines in tissue-specific and microenvironment-specific lymphocyte homing Curr Opin Immunol 12 336 10.1016/S0952-7915(00)00096-0 (Pubitemid 30240545)
46. D Soler TL Humphreys SM Spinola JJ Campbell 2003 CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking Blood 101 1677 10.1182/blood-2002-07- 2348 (Pubitemid 36237558)
47. + T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1/I-309 Eur J Immunol 32 3506 10.1002/1521-4141(200212)32:12<3506::AID- IMMU3506>3.0.CO;2-# (Pubitemid 36024387)
48. + T cells specific for a skin-tropic virus J Clin Invest 110 537
49. JC Dudda SF Martin 2004 Tissue targeting of T cells by DCs and microenvironments Trends Immunol 25 417 10.1016/j.it.2004.05.008 (Pubitemid 38951082)
50. B Homey A Müller A Zlotnik 2002 Chemokines: agents for the immunotherapy of cancer? Nat Rev Immunol 2 175 10.1038/nri748
51. J Morales B Homey AP Vicari S Hudak E Oldham J Hedrick R Orozco NG Copeland NA Jenkins LM McEvoy A Zlotnik 1999 CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells Proc Natl Acad Sci USA 96 14470 10.1073/pnas.96.25.14470 (Pubitemid 30000674)
52. T Engeman AV Gorbachev DD Kish RL Fairchild 2004 The intensity of neutrophil infiltration controls the number of antigen-primed CD8 T cells recruited into cutaneous antigen challenge sites J Leukoc Biol 76 941 10.1189/jlb.0304193 (Pubitemid 39458706)
53. C Reis e Sousa S Hieny T Scharton-Kersten D Jankovic H Charest RN Germain A Sher 1997 In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas J Exp Med 186 1819 10.1084/jem.186.11.1819 (Pubitemid 27524592)
54. E von Stebut Y Belkaid T Jakob DL Sacks MC Udey 1998 Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity J Exp Med 188 1547 10.1084/jem.188.8.1547 (Pubitemid 28489593)
55. RL Modlin 1994 Th1-Th2 paradigm: insights from leprosy J Invest Dermatol 102 828 10.1111/1523-1747.ep12381958
56. Y Iwakura H Ishigame 2006 The IL-23/IL-17 axis in inflammation J Clin Invest 116 1218 10.1172/JCI28508
57. TA Wynn 2005 Th-17: a giant step from Th1 and Th2 Nat Immunol 6 1069 10.1038/ni1105-1069 (Pubitemid 41541781)
58. CM Tato JJ O'Shea 2006 Immunology: what does it mean to be just 17? Nature 441 166 10.1038/441166a
59. Lopez Kostka S, Dinges S, Iwakura Y, Udey MC, von Stebut E (2009) IL-17 contributes to disease susceptibility in cutaneous leishmaniasis. J Immunol 182: (in press). doi: 10.4049/jimmunol.0713598
60. + Th2 response in BALB/c mice infected with Leishmania major J Immunol 165 2628
61. FL Ribeiro-Gomes AC Otero NA Gomes MC Moniz-De-Souza L Cysne-Finkelstein AC Arnholdt VL Calich SG Coutinho MF Lopes GA DosReis 2004 Macrophage interactions with neutrophils regulate Leishmania major infection J Immunol 172 4454
62. + regulatory T cells in Leishmania infection Expert Opin Biol Ther 3 875 10.1517/14712598.3.6. 875 (Pubitemid 37093142)
63. LS Ou E Goleva C Hall DY Leung 2004 T regulatory cells in atopic dermatitis and subversion of their activity by superantigens J Allergy Clin Immunol 113 756 10.1016/j.jaci.2004.01.772 (Pubitemid 38530433)
64. H Jonuleit E Schmitt K Steinbrink AH Enk 2001 Dendritic cells as a tool to induce anergic and regulatory T cells Trends Immunol 22 394 10.1016/S1471-4906(01)01952-4 (Pubitemid 32673646)
65. Y Belkaid KF Hoffmann S Mendez S Kamhawi MC Udey TA Wynn DL Sacks 2001 The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure J Exp Med 194 1497 10.1084/jem.194.10.1497 (Pubitemid 33081524)
66. E von Stebut JM Ehrchen Y Belkaid S Lopez Kostka K Mölle J Knop C Sunderkötter MC Udey 2003 IL-1α promotes Th1-differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice J Exp Med 198 191 10.1084/jem.20030159 (Pubitemid 36992177)
67. AP Nigg S Zahn D Rückerl C Hölscher T Yoshimoto JM Ehrchen F Wölbing MC Udey E von Stebut 2007 Dendritic cell-derived IL-12p40 homodimer contributes to susceptibility in cutaneous leishmaniasis in BALB/c mice J Immunol 178 7251
68. K Loser S Beissert 2007 Dendritic cells and T cells in the regulation of cutaneous immunity Adv Dermatol 23 307 333 10.1016/j.yadr.2007.07.014
69. L Carrera RT Gazzinelli R Badolato S Hieny W Muller R Kuhn DL Sacks 1996 Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice J Exp Med 183 515 10.1084/jem.183.2.515 (Pubitemid 26059515)
70. Y Belkaid B Butcher DL Sacks 1998 Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells Eur J Immunol 28 1389 10.1002/(SICI)1521-4141(199804)28:04<1389::AID-IMMU1389>3.0.CO;2-1
71. F Schönlau K Scharffetter-Kochanek S Grabbe B Pietz C Sorg C Sunderkötter 2000 In experimental leishmaniasis deficiency of CD18 results in parasite dissemination associated with altered macrophage functions and incomplete Th1 cell response Eur J Immunol 30 2729 10.1002/1521-4141(200009)30: 9<2729::AID-IMMU2729>3.0.CO;2-3
72. DM Mosser A Brittingham 1997 Leishmania, macrophages and complement: a tale of subversion and exploitation Parasitology 115 Suppl S9 10.1017/S0031182097001789
73. C Bogdan M Röllinghoff 1998 The immune response to Leishmania: mechanisms of parasite control and evasion Int J Parasitol 28 121 10.1016/S0020-7519(97)00169-0 (Pubitemid 28082065)
74. D Sacks A Sher 2002 Evasion of innate immunity by parasitic protozoa Nat Immunol 3 1041 10.1038/ni1102-1041 (Pubitemid 35363655)
75. + T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice Immunity 6 541 10.1016/S1074-7613(00)80342-8 (Pubitemid 27239345)
76. V Julia M Rassoulzadegan N Glaichenhaus 1996 Resistance to Leishmania major induced by tolerance to a single antigen Science 274 421 10.1126/science.274.5286.421 (Pubitemid 26353355)
77. + T cells in resistant mice upon infection with Leishmania major Immunity 13 771 10.1016/S1074-7613(00)00075-3 (Pubitemid 32041800)